199 related articles for article (PubMed ID: 25471892)
1. Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma.
Lynam-Lennon N; Connaughton R; Carr E; Mongan AM; O'Farrell NJ; Porter RK; Brennan L; Pidgeon GP; Lysaght J; Reynolds JV; O'Sullivan J
BMC Cancer; 2014 Dec; 14():907. PubMed ID: 25471892
[TBL] [Abstract][Full Text] [Related]
2. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
[TBL] [Abstract][Full Text] [Related]
3. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition.
Brandi J; Cecconi D; Cordani M; Torrens-Mas M; Pacchiana R; Dalla Pozza E; Butera G; Manfredi M; Marengo E; Oliver J; Roca P; Dando I; Donadelli M
Free Radic Biol Med; 2016 Dec; 101():305-316. PubMed ID: 27989750
[TBL] [Abstract][Full Text] [Related]
4. Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma.
Mongan AM; Lynam-Lennon N; Doyle SL; Casey R; Carr E; Cannon A; Conroy MJ; Pidgeon GP; Brennan L; Lysaght J; Reynolds JV; O'Sullivan J
Int J Med Sci; 2019; 16(4):519-528. PubMed ID: 31171903
[TBL] [Abstract][Full Text] [Related]
5. Visceral adipose tissue: the link with esophageal adenocarcinoma.
Massl R; van Blankenstein M; Jeurnink S; Hermans JJ; de Haan MC; Stoker J; Koek M; Niessen WJ; Steyerberg EW; Looman CW; Kuipers EJ
Scand J Gastroenterol; 2014 Apr; 49(4):449-57. PubMed ID: 24467299
[TBL] [Abstract][Full Text] [Related]
6. A high-fat diet is associated with altered adipokine production and a more aggressive esophageal adenocarcinoma phenotype in vivo.
Fowler AJ; Richer AL; Bremner RM; Inge LJ
J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1185-91. PubMed ID: 25595377
[TBL] [Abstract][Full Text] [Related]
7. Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma.
Mongan AM; Lynam-Lennon N; Casey R; Maher S; Pidgeon G; Reynolds JV; O'Sullivan J
Clin Transl Oncol; 2016 Jun; 18(6):632-40. PubMed ID: 26474871
[TBL] [Abstract][Full Text] [Related]
8. Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion.
Trevellin E; Scarpa M; Carraro A; Lunardi F; Kotsafti A; Porzionato A; Saadeh L; Cagol M; Alfieri R; Tedeschi U; Calabrese F; Castoro C; Vettor R
Oncotarget; 2015 May; 6(13):11203-15. PubMed ID: 25857300
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus.
Phelan JJ; MacCarthy F; Feighery R; O'Farrell NJ; Lynam-Lennon N; Doyle B; O'Toole D; Ravi N; Reynolds JV; O'Sullivan J
Cancer Lett; 2014 Nov; 354(1):122-31. PubMed ID: 25107643
[TBL] [Abstract][Full Text] [Related]
10. Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma.
Li H; Bai E; Zhang Y; Jia Z; He S; Fu J
J Immunol Res; 2017; 2017():3970605. PubMed ID: 28168205
[TBL] [Abstract][Full Text] [Related]
11. Glucose-deprivation increases thyroid cancer cells sensitivity to metformin.
Bikas A; Jensen K; Patel A; Costello J; McDaniel D; Klubo-Gwiezdzinska J; Larin O; Hoperia V; Burman KD; Boyle L; Wartofsky L; Vasko V
Endocr Relat Cancer; 2015 Dec; 22(6):919-32. PubMed ID: 26362676
[TBL] [Abstract][Full Text] [Related]
12. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma.
Donohoe CL; Doyle SL; McGarrigle S; Cathcart MC; Daly E; O'Grady A; Lysaght J; Pidgeon GP; Reynolds JV
Br J Surg; 2012 Mar; 99(3):387-96. PubMed ID: 22241325
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms linking obesity to altered metabolism in mice colon carcinogenesis.
Nimri L; Saadi J; Peri I; Yehuda-Shnaidman E; Schwartz B
Oncotarget; 2015 Nov; 6(35):38195-209. PubMed ID: 26472027
[TBL] [Abstract][Full Text] [Related]
14. α-Lactalbumin-oleic acid complex kills tumor cells by inducing excess energy metabolism but inhibiting mRNA expression of the related enzymes.
Fang B; Zhang M; Ge KS; Xing HZ; Ren FZ
J Dairy Sci; 2018 Jun; 101(6):4853-4863. PubMed ID: 29550120
[TBL] [Abstract][Full Text] [Related]
15. Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.
Allott EH; Morine MJ; Lysaght J; McGarrigle SA; Donohoe CL; Reynolds JV; Roche HM; Pidgeon GP
Clin Transl Gastroenterol; 2012 Apr; 3(4):e12. PubMed ID: 23238211
[TBL] [Abstract][Full Text] [Related]
16. Visceral obesity and colorectal cancer: are we missing the boat with BMI?
Rickles AS; Iannuzzi JC; Mironov O; Deeb AP; Sharma A; Fleming FJ; Monson JR
J Gastrointest Surg; 2013 Jan; 17(1):133-43; discussion p.143. PubMed ID: 23090279
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
19. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
20. Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma.
Doyle SL; Mongan AM; Donohoe CL; Pidgeon GP; Sherlock M; Reynolds JV; Lysaght J
Dis Esophagus; 2017 Jun; 30(6):1-11. PubMed ID: 28475745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
